Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro
Little is known about the interaction of novel anticancer drugs with other treatment modalities. The aim of this study was to examine the effect of combining imatinib mesylate (STI-571) with radiation or cisplatin on the survival of two human solid tumor cell lines – SKNMC cells derived from Ewing s...
Gespeichert in:
Datum: | 2007 |
---|---|
Hauptverfasser: | Yerushalmi, R., Nordenberg, J., Beery, E., Uziel, O., Lahav, M., Luria, D., Fenig, E. |
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2007
|
Schriftenreihe: | Experimental Oncology |
Schlagworte: | |
Online Zugang: | http://dspace.nbuv.gov.ua/handle/123456789/138577 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Zitieren: | Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro / R. Yerushalmi, J. Nordenberg, E. Beery, O. Uziel, M. Lahav, D. Luria, E. Fenig // Experimental Oncology. — 2007. — Т. 29, № 2. — С. 126–131. — Бібліогр.: 29 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineÄhnliche Einträge
-
In vitro modification of cisplatin cytotoxicity with magnetic fluid
von: Chekhun, V.F., et al.
Veröffentlicht: (2013) -
Biodistribution analysis of cisplatin in liposomal form in animals with cisplatinresistant and cisplatin-sensitive carcinoma
von: Nosko, M.M., et al.
Veröffentlicht: (2010) -
Generic imatinib in the treatment of chronic myeloid leukemia: two years’ experience in latvia
von: Lejniece, S., et al.
Veröffentlicht: (2017) -
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
von: Sviezhentseva, I.O., et al.
Veröffentlicht: (2015) -
Enterosorption as a method to decrease the systemic toxicity of cisplatin
von: Sakhno, L.A., et al.
Veröffentlicht: (2013)